At least 40 million people worldwide have Alzheimer’s disease, and that number is expected to grow larger as the baby boomers grow older. But no real progress has been made in more than 100 years. Scientist Samuel Cohen shares a new breakthrough in Alzheimer’s research, “Alzheimer’s is a disease,” Cohen says, “and we can cure it.”
Who is he:
Samuel Cohen is a Research Fellow in Biophysical Chemistry at St. John’s College and the Centre for Misfolding Diseases in the Department of Chemistry at the University of Cambridge, from where he holds PhD, MSci, MA and BA degrees.
Why you should listen:
Cohen has been a consultant in the London office of Boston Consulting Group (BCG), where he specialized in the healthcare, technology and media sectors. His research focuses on neurodegenerative disorders. He is co-author of more than 20 scientific papers, book chapters and patents. He is the lead author on a study showing that researchers have made a major breakthrough in finding a cure for Alzheimer’s disease.
- Cohen say that if the first patient to be diagnosed with Alzheimer’s disease were alive today, we would offer 1) more, 2) less or 3) the same help she got 114 years ago.
- Of the top 10 most life threatening diseases, Coen says that the only one that we cannot prevent, treat, or even slow down is …………
- In discussing the costs of the disease, he says that 1 in ………. Medicare dollars is spent on Alzheimer’s.
- For many of us, it seems that dementia is a logical end of life event. Cohen says that this lack of awareness costs patients’ lives and affects caregiver’s quality of life. Explain what he means to someone.
- What was the test subject of the potential treatment?
- At the end of his talk, Cohen issues a call to action. What is it?
Making Connections: New Drug May Slow Alzheimer’s Disease – http://www.nbcnews.com/health/health-news/new-drug-might-slow-alzheimers-n327121